APO Research
Talk to an analyst

APO RESEARCH · REPORT

External Anti-infective Preparations

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global External Anti-infective Preparations Industry Growth and Trends Forecast to 2032

23 December 2025120 pages

Choose your research edition.

Industry ResearchExternal Anti-infective Preparations Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal External Anti-infective Preparations Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal External Anti-infective Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal External Anti-infective Preparations Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal External Anti-infective Preparations Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global External Anti-infective Preparations market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for External Anti-infective Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for External Anti-infective Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for External Anti-infective Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the External Anti-infective Preparations market include SK-SF, Zhejiang Funo Pharmaceuticals, Teva, Sun Pharmaceutical, Shandong Jingwei Pharmaceuticals, Sandoz, J & J, Liaoning Xingao Pharmaceuticals and Jiangsu Zhiyuan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global External Anti-infective Preparations market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The External Anti-infective Preparations market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global External Anti-infective Preparations market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to External Anti-infective Preparations.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global External Anti-infective Preparations market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

External Anti-infective Preparations Market by Company

SK-SF

Zhejiang Funo Pharmaceuticals

Teva

Sun Pharmaceutical

Shandong Jingwei Pharmaceuticals

Sandoz

J & J

Liaoning Xingao Pharmaceuticals

Jiangsu Zhiyuan Pharmaceuticals

Jiangsu Fubang Pharmaceuticals

Hubei Renfu

Bayer

STADA Arzneimittel

LEO Pharma

Kaken Pharmaceutical

Haleon

Glenmark Pharmaceuticals

Galderma

Bausch Health

Almirall

External Anti-infective Preparations Segment by Type

Ointment

Solution

Gel

Other

External Anti-infective Preparations Segment by Application

Hospital

Retail Phamracy

Other

External Anti-infective Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global External Anti-infective Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of External Anti-infective Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of External Anti-infective Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of External Anti-infective Preparations companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global External Anti-infective Preparations Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global External Anti-infective Preparations Market Size by Region (2021-2026) & (US$ Million) Table 3. Global External Anti-infective Preparations Market Share by Region (2021-2026) Table 4. Global External Anti-infective Preparations Market Size by Region (2027-2032) & (US$ Million) Table 5. Global External Anti-infective Preparations Market Share by Region (2027-2032) Table 6. Global External Anti-infective Preparations Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global External Anti-infective Preparations Market Size by Type (2021-2026) & (US$ Million) Table 8. Global External Anti-infective Preparations Market Size Share by Type (2021-2026) Table 9. Global External Anti-infective Preparations Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global External Anti-infective Preparations Market Size Share Forecasted by Type (2027-2032) Table 11. North America External Anti-infective Preparations Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America External Anti-infective Preparations Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe External Anti-infective Preparations Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe External Anti-infective Preparations Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific External Anti-infective Preparations Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific External Anti-infective Preparations Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America External Anti-infective Preparations Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America External Anti-infective Preparations Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa External Anti-infective Preparations Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa External Anti-infective Preparations Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global External Anti-infective Preparations Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global External Anti-infective Preparations Market Size by Application (2021-2026) & (US$ Million) Table 23. Global External Anti-infective Preparations Market Size Share by Application (2021-2026) Table 24. Global External Anti-infective Preparations Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global External Anti-infective Preparations Market Size Share Forecasted by Application (2027-2032) Table 26. North America External Anti-infective Preparations Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America External Anti-infective Preparations Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe External Anti-infective Preparations Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe External Anti-infective Preparations Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific External Anti-infective Preparations Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific External Anti-infective Preparations Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America External Anti-infective Preparations Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America External Anti-infective Preparations Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa External Anti-infective Preparations Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa External Anti-infective Preparations Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. External Anti-infective Preparations Industry Trends Table 37. External Anti-infective Preparations Industry Drivers Table 38. External Anti-infective Preparations Industry Opportunities and Challenges Table 39. External Anti-infective Preparations Industry Restraints Table 40. Global External Anti-infective Preparations Revenue by Company (US$ Million) & (2021-2026) Table 41. Global External Anti-infective Preparations Revenue Market Share by Company (2021-2026) Table 42. Global External Anti-infective Preparations Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global External Anti-infective Preparations Key Company Headquarters & Area Served Table 44. Global External Anti-infective Preparations Company, Product Type & Application Table 45. Global External Anti-infective Preparations Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global External Anti-infective Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. SK-SF Company Information Table 49. SK-SF Business Overview Table 50. SK-SF External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. SK-SF External Anti-infective Preparations Product Portfolio Table 52. SK-SF Recent Development Table 53. Zhejiang Funo Pharmaceuticals Company Information Table 54. Zhejiang Funo Pharmaceuticals Business Overview Table 55. Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 57. Zhejiang Funo Pharmaceuticals Recent Development Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Teva External Anti-infective Preparations Product Portfolio Table 62. Teva Recent Development Table 63. Sun Pharmaceutical Company Information Table 64. Sun Pharmaceutical Business Overview Table 65. Sun Pharmaceutical External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical External Anti-infective Preparations Product Portfolio Table 67. Sun Pharmaceutical Recent Development Table 68. Shandong Jingwei Pharmaceuticals Company Information Table 69. Shandong Jingwei Pharmaceuticals Business Overview Table 70. Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 72. Shandong Jingwei Pharmaceuticals Recent Development Table 73. Sandoz Company Information Table 74. Sandoz Business Overview Table 75. Sandoz External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Sandoz External Anti-infective Preparations Product Portfolio Table 77. Sandoz Recent Development Table 78. J & J Company Information Table 79. J & J Business Overview Table 80. J & J External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. J & J External Anti-infective Preparations Product Portfolio Table 82. J & J Recent Development Table 83. Liaoning Xingao Pharmaceuticals Company Information Table 84. Liaoning Xingao Pharmaceuticals Business Overview Table 85. Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 87. Liaoning Xingao Pharmaceuticals Recent Development Table 88. Jiangsu Zhiyuan Pharmaceuticals Company Information Table 89. Jiangsu Zhiyuan Pharmaceuticals Business Overview Table 90. Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 92. Jiangsu Zhiyuan Pharmaceuticals Recent Development Table 93. Jiangsu Fubang Pharmaceuticals Company Information Table 94. Jiangsu Fubang Pharmaceuticals Business Overview Table 95. Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 97. Jiangsu Fubang Pharmaceuticals Recent Development Table 98. Hubei Renfu Company Information Table 99. Hubei Renfu Business Overview Table 100. Hubei Renfu External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Hubei Renfu External Anti-infective Preparations Product Portfolio Table 102. Hubei Renfu Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bayer External Anti-infective Preparations Product Portfolio Table 107. Bayer Recent Development Table 108. STADA Arzneimittel Company Information Table 109. STADA Arzneimittel Business Overview Table 110. STADA Arzneimittel External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. STADA Arzneimittel External Anti-infective Preparations Product Portfolio Table 112. STADA Arzneimittel Recent Development Table 113. LEO Pharma Company Information Table 114. LEO Pharma Business Overview Table 115. LEO Pharma External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. LEO Pharma External Anti-infective Preparations Product Portfolio Table 117. LEO Pharma Recent Development Table 118. Kaken Pharmaceutical Company Information Table 119. Kaken Pharmaceutical Business Overview Table 120. Kaken Pharmaceutical External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Kaken Pharmaceutical External Anti-infective Preparations Product Portfolio Table 122. Kaken Pharmaceutical Recent Development Table 123. Haleon Company Information Table 124. Haleon Business Overview Table 125. Haleon External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Haleon External Anti-infective Preparations Product Portfolio Table 127. Haleon Recent Development Table 128. Glenmark Pharmaceuticals Company Information Table 129. Glenmark Pharmaceuticals Business Overview Table 130. Glenmark Pharmaceuticals External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Glenmark Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 132. Glenmark Pharmaceuticals Recent Development Table 133. Galderma Company Information Table 134. Galderma Business Overview Table 135. Galderma External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Galderma External Anti-infective Preparations Product Portfolio Table 137. Galderma Recent Development Table 138. Bausch Health Company Information Table 139. Bausch Health Business Overview Table 140. Bausch Health External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Bausch Health External Anti-infective Preparations Product Portfolio Table 142. Bausch Health Recent Development Table 143. Almirall Company Information Table 144. Almirall Business Overview Table 145. Almirall External Anti-infective Preparations Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Almirall External Anti-infective Preparations Product Portfolio Table 147. Almirall Recent Development Table 148. North America External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America External Anti-infective Preparations Market Size by Country (2021-2026) & (US$ Million) Table 150. North America External Anti-infective Preparations Market Share by Country (2021-2026) Table 151. North America External Anti-infective Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America External Anti-infective Preparations Market Share Forecast by Country (2027-2032) Table 153. Europe External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe External Anti-infective Preparations Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe External Anti-infective Preparations Market Share by Country (2021-2026) Table 156. Europe External Anti-infective Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe External Anti-infective Preparations Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific External Anti-infective Preparations Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific External Anti-infective Preparations Market Share by Country (2021-2026) Table 161. Asia-Pacific External Anti-infective Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific External Anti-infective Preparations Market Share Forecast by Country (2027-2032) Table 163. Latin America External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America External Anti-infective Preparations Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America External Anti-infective Preparations Market Share by Country (2021-2026) Table 166. Latin America External Anti-infective Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America External Anti-infective Preparations Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa External Anti-infective Preparations Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa External Anti-infective Preparations Market Share by Country (2021-2026) Table 171. Middle East & Africa External Anti-infective Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa External Anti-infective Preparations Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. External Anti-infective Preparations Product Image Figure 3. Global External Anti-infective Preparations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 5. Global External Anti-infective Preparations Market Share by Region: 2025 VS 2032 Figure 6. Global External Anti-infective Preparations Market Share by Region (2021-2032) Figure 7. North America External Anti-infective Preparations Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe External Anti-infective Preparations Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific External Anti-infective Preparations Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America External Anti-infective Preparations Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa External Anti-infective Preparations Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Ointment Image Figure 13. Global Ointment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Solution Image Figure 15. Global Solution Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Gel Image Figure 17. Global Gel Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global External Anti-infective Preparations Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global External Anti-infective Preparations Market Share by Type 2025 VS 2032 Figure 22. North America External Anti-infective Preparations Market Size Share by Type (2021-2032) Figure 23. Europe External Anti-infective Preparations Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific External Anti-infective Preparations Market Size Share by Type (2021-2032) Figure 25. Latin America External Anti-infective Preparations Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa External Anti-infective Preparations Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Retail Phamracy Image Figure 30. Global Retail Phamracy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global External Anti-infective Preparations Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global External Anti-infective Preparations Market Share by Application 2025 VS 2032 Figure 35. North America External Anti-infective Preparations Market Size Share by Application (2021-2032) Figure 36. Europe External Anti-infective Preparations Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific External Anti-infective Preparations Market Size Share by Application (2021-2032) Figure 38. Latin America External Anti-infective Preparations Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa External Anti-infective Preparations Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 External Anti-infective Preparations Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America External Anti-infective Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America External Anti-infective Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America External Anti-infective Preparations Market Share by Country (2021-2032) Figure 45. Europe External Anti-infective Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe External Anti-infective Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe External Anti-infective Preparations Market Share by Country (2021-2032) Figure 48. Asia-Pacific External Anti-infective Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific External Anti-infective Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific External Anti-infective Preparations Market Share by Country (2021-2032) Figure 51. Latin America External Anti-infective Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America External Anti-infective Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America External Anti-infective Preparations Market Share by Country (2021-2032) Figure 54. Middle East & Africa External Anti-infective Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa External Anti-infective Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa External Anti-infective Preparations Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Ointment
  • Solution
  • Gel
  • Other
Applications
  • Hospital
  • Retail Phamracy
  • Other
Companies covered
  • SK-SF
  • Zhejiang Funo Pharmaceuticals
  • Teva
  • Sun Pharmaceutical
  • Shandong Jingwei Pharmaceuticals
  • Sandoz
  • J & J
  • Liaoning Xingao Pharmaceuticals
  • Jiangsu Zhiyuan Pharmaceuticals
  • Jiangsu Fubang Pharmaceuticals
  • Hubei Renfu
  • Bayer
  • STADA Arzneimittel
  • LEO Pharma
  • Kaken Pharmaceutical
  • Haleon
  • Glenmark Pharmaceuticals
  • Galderma
  • Bausch Health
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global External Anti-infective Preparations Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global External Anti-infective Preparations Market Size by Region (2021-2032)
  5. 1.4.1 Global External Anti-infective Preparations Market Size by Region (2021-2026)
  6. 1.4.2 Global External Anti-infective Preparations Market Size by Region (2027-2032)
  7. 1.5 Key Regions External Anti-infective Preparations Market Size (2021-2032)
  8. 1.5.1 North America External Anti-infective Preparations Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe External Anti-infective Preparations Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific External Anti-infective Preparations Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America External Anti-infective Preparations Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa External Anti-infective Preparations Market Size Growth Rate (2021-2032)
2 External Anti-infective Preparations Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Ointment
  3. 2.1.2 Solution
  4. 2.1.3 Gel
  5. 2.1.4 Other
  6. 2.2 Global External Anti-infective Preparations Market Size by Type
  7. 2.2.1 Global External Anti-infective Preparations Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global External Anti-infective Preparations Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global External Anti-infective Preparations Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global External Anti-infective Preparations Market Size by Regions
  11. 2.3.1 North America External Anti-infective Preparations Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe External Anti-infective Preparations Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific External Anti-infective Preparations Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America External Anti-infective Preparations Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa External Anti-infective Preparations Market Size Breakdown by Type (2021-2026)
3 External Anti-infective Preparations Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Phamracy
  4. 3.1.3 Other
  5. 3.2 Global External Anti-infective Preparations Market Size by Application
  6. 3.2.1 Global External Anti-infective Preparations Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global External Anti-infective Preparations Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global External Anti-infective Preparations Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global External Anti-infective Preparations Market Size by Regions
  10. 3.3.1 North America External Anti-infective Preparations Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe External Anti-infective Preparations Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific External Anti-infective Preparations Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America External Anti-infective Preparations Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa External Anti-infective Preparations Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 External Anti-infective Preparations Industry Trends
  2. 4.2 External Anti-infective Preparations Industry Drivers
  3. 4.3 External Anti-infective Preparations Industry Opportunities and Challenges
  4. 4.4 External Anti-infective Preparations Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by External Anti-infective Preparations Revenue (2021-2026)
  2. 5.2 Global External Anti-infective Preparations Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global External Anti-infective Preparations Key Company Headquarters & Area Served
  4. 5.4 Global External Anti-infective Preparations Company, Product Type & Application
  5. 5.5 Global External Anti-infective Preparations Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global External Anti-infective Preparations Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 External Anti-infective Preparations Players Market Share by Revenue in 2025
  9. 5.6.3 2025 External Anti-infective Preparations Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 SK-SF
  2. 6.1.1 SK-SF Company Information
  3. 6.1.2 SK-SF Business Overview
  4. 6.1.3 SK-SF External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 SK-SF External Anti-infective Preparations Product Portfolio
  6. 6.1.5 SK-SF Recent Developments
  7. 6.2 Zhejiang Funo Pharmaceuticals
  8. 6.2.1 Zhejiang Funo Pharmaceuticals Company Information
  9. 6.2.2 Zhejiang Funo Pharmaceuticals Business Overview
  10. 6.2.3 Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Product Portfolio
  12. 6.2.5 Zhejiang Funo Pharmaceuticals Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Teva External Anti-infective Preparations Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Sun Pharmaceutical
  20. 6.4.1 Sun Pharmaceutical Company Information
  21. 6.4.2 Sun Pharmaceutical Business Overview
  22. 6.4.3 Sun Pharmaceutical External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sun Pharmaceutical External Anti-infective Preparations Product Portfolio
  24. 6.4.5 Sun Pharmaceutical Recent Developments
  25. 6.5 Shandong Jingwei Pharmaceuticals
  26. 6.5.1 Shandong Jingwei Pharmaceuticals Company Information
  27. 6.5.2 Shandong Jingwei Pharmaceuticals Business Overview
  28. 6.5.3 Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Product Portfolio
  30. 6.5.5 Shandong Jingwei Pharmaceuticals Recent Developments
  31. 6.6 Sandoz
  32. 6.6.1 Sandoz Company Information
  33. 6.6.2 Sandoz Business Overview
  34. 6.6.3 Sandoz External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Sandoz External Anti-infective Preparations Product Portfolio
  36. 6.6.5 Sandoz Recent Developments
  37. 6.7 J & J
  38. 6.7.1 J & J Company Information
  39. 6.7.2 J & J Business Overview
  40. 6.7.3 J & J External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 J & J External Anti-infective Preparations Product Portfolio
  42. 6.7.5 J & J Recent Developments
  43. 6.8 Liaoning Xingao Pharmaceuticals
  44. 6.8.1 Liaoning Xingao Pharmaceuticals Company Information
  45. 6.8.2 Liaoning Xingao Pharmaceuticals Business Overview
  46. 6.8.3 Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Product Portfolio
  48. 6.8.5 Liaoning Xingao Pharmaceuticals Recent Developments
  49. 6.9 Jiangsu Zhiyuan Pharmaceuticals
  50. 6.9.1 Jiangsu Zhiyuan Pharmaceuticals Company Information
  51. 6.9.2 Jiangsu Zhiyuan Pharmaceuticals Business Overview
  52. 6.9.3 Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Product Portfolio
  54. 6.9.5 Jiangsu Zhiyuan Pharmaceuticals Recent Developments
  55. 6.10 Jiangsu Fubang Pharmaceuticals
  56. 6.10.1 Jiangsu Fubang Pharmaceuticals Company Information
  57. 6.10.2 Jiangsu Fubang Pharmaceuticals Business Overview
  58. 6.10.3 Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Product Portfolio
  60. 6.10.5 Jiangsu Fubang Pharmaceuticals Recent Developments
  61. 6.11 Hubei Renfu
  62. 6.11.1 Hubei Renfu Company Information
  63. 6.11.2 Hubei Renfu Business Overview
  64. 6.11.3 Hubei Renfu External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Hubei Renfu External Anti-infective Preparations Product Portfolio
  66. 6.11.5 Hubei Renfu Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bayer External Anti-infective Preparations Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 STADA Arzneimittel
  74. 6.13.1 STADA Arzneimittel Company Information
  75. 6.13.2 STADA Arzneimittel Business Overview
  76. 6.13.3 STADA Arzneimittel External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 STADA Arzneimittel External Anti-infective Preparations Product Portfolio
  78. 6.13.5 STADA Arzneimittel Recent Developments
  79. 6.14 LEO Pharma
  80. 6.14.1 LEO Pharma Company Information
  81. 6.14.2 LEO Pharma Business Overview
  82. 6.14.3 LEO Pharma External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 LEO Pharma External Anti-infective Preparations Product Portfolio
  84. 6.14.5 LEO Pharma Recent Developments
  85. 6.15 Kaken Pharmaceutical
  86. 6.15.1 Kaken Pharmaceutical Company Information
  87. 6.15.2 Kaken Pharmaceutical Business Overview
  88. 6.15.3 Kaken Pharmaceutical External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Kaken Pharmaceutical External Anti-infective Preparations Product Portfolio
  90. 6.15.5 Kaken Pharmaceutical Recent Developments
  91. 6.16 Haleon
  92. 6.16.1 Haleon Company Information
  93. 6.16.2 Haleon Business Overview
  94. 6.16.3 Haleon External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Haleon External Anti-infective Preparations Product Portfolio
  96. 6.16.5 Haleon Recent Developments
  97. 6.17 Glenmark Pharmaceuticals
  98. 6.17.1 Glenmark Pharmaceuticals Company Information
  99. 6.17.2 Glenmark Pharmaceuticals Business Overview
  100. 6.17.3 Glenmark Pharmaceuticals External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Glenmark Pharmaceuticals External Anti-infective Preparations Product Portfolio
  102. 6.17.5 Glenmark Pharmaceuticals Recent Developments
  103. 6.18 Galderma
  104. 6.18.1 Galderma Company Information
  105. 6.18.2 Galderma Business Overview
  106. 6.18.3 Galderma External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Galderma External Anti-infective Preparations Product Portfolio
  108. 6.18.5 Galderma Recent Developments
  109. 6.19 Bausch Health
  110. 6.19.1 Bausch Health Company Information
  111. 6.19.2 Bausch Health Business Overview
  112. 6.19.3 Bausch Health External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Bausch Health External Anti-infective Preparations Product Portfolio
  114. 6.19.5 Bausch Health Recent Developments
  115. 6.20 Almirall
  116. 6.20.1 Almirall Company Information
  117. 6.20.2 Almirall Business Overview
  118. 6.20.3 Almirall External Anti-infective Preparations Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Almirall External Anti-infective Preparations Product Portfolio
  120. 6.20.5 Almirall Recent Developments
7 North America
  1. 7.1 North America External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America External Anti-infective Preparations Market Size by Country (2021-2026)
  3. 7.3 North America External Anti-infective Preparations Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe External Anti-infective Preparations Market Size by Country (2021-2026)
  3. 8.3 Europe External Anti-infective Preparations Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific External Anti-infective Preparations Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific External Anti-infective Preparations Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America External Anti-infective Preparations Market Size by Country (2021-2026)
  3. 10.3 South America External Anti-infective Preparations Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa External Anti-infective Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa External Anti-infective Preparations Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa External Anti-infective Preparations Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst